4-24819861-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001395273.1(CCDC149):āc.1175A>Gā(p.Asp392Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000252 in 1,550,452 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001395273.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC149 | NM_001395273.1 | c.1175A>G | p.Asp392Gly | missense_variant, splice_region_variant | 12/13 | ENST00000635206.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC149 | ENST00000635206.3 | c.1175A>G | p.Asp392Gly | missense_variant, splice_region_variant | 12/13 | 5 | NM_001395273.1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152010Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000102 AC: 16AN: 156526Hom.: 0 AF XY: 0.0000844 AC XY: 7AN XY: 82950
GnomAD4 exome AF: 0.0000236 AC: 33AN: 1398324Hom.: 0 Cov.: 30 AF XY: 0.0000217 AC XY: 15AN XY: 689764
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.1157A>G (p.D386G) alteration is located in exon 12 (coding exon 11) of the CCDC149 gene. This alteration results from a A to G substitution at nucleotide position 1157, causing the aspartic acid (D) at amino acid position 386 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at